top of page
Untitled design (14).png

Work by Element Eleven and Filip Surmont led to a Late-Breaking Poster presentation at the American Society of Nephrology (ASN) Kidney Week 2025, showcasing novel evidence of kidney benefit with HTD1801.

PRESS RELEASE:

2025 ASN 最新突破性专场 | 君圣泰医药展示HTD1801肾脏获益数据

In October 2025 Filip Surmont was invited to serve as a Board Member of iCTS (Intelligent Clinical Trials Solutions), a pioneering organisation tackling the shortage of quality Clinical Trials Management in high-need communities through innovative CTM services

Filip Surmont’s work with Element Eleven contributed to a Late-Breaking Clinical Trial presented at the European Society of Cardiology Heart Failure Congress 2025, showcasing an AI-enabled ECG algorithm for detecting heart failure across nearly 6,000 adults in Kenya — advancing accessible, data-driven healthcare innovation in low-resource settings.

bottom of page